Athenex Pharma Solutions, LLC recalls Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex P…
- Recall date
- March 14, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0708-2022
- FDA classification
- Class II
- Brand / firm
- Athenex Pharma Solutions, LLC
- Sold / distributed
- USA nationwide.
Why it was recalled
Defective container
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-475-15
Get recall alerts
Free email alert whenever Athenex Pharma Solutions, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Athenex Pharma Solutions, LLC